C
Cristina Marzano
Researcher at University of Padua
Publications - 133
Citations - 6648
Cristina Marzano is an academic researcher from University of Padua. The author has contributed to research in topics: Cisplatin & DNA damage. The author has an hindex of 38, co-authored 124 publications receiving 5628 citations. Previous affiliations of Cristina Marzano include University of Camerino.
Papers
More filters
Journal ArticleDOI
Advances in copper complexes as anticancer agents.
Carlo Santini,Maura Pellei,Valentina Gandin,Marina Porchia,Francesco Tisato,Cristina Marzano +5 more
Journal ArticleDOI
Copper complexes as anticancer agents
TL;DR: This overview, collecting the most significant strategies adopted in the last ten years to design promising anticancer copper(I,II) compounds, would be a help to the researchers working in this field.
Journal ArticleDOI
Copper in diseases and treatments, and copper-based anticancer strategies.
TL;DR: Investigations into the occurrence of mechanisms of action quite different from platinum drugs head toward the development of new anticancer metallodrugs with improved specificity and decreased toxic side effects.
Journal ArticleDOI
Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
Valentina Gandin,Aristi P. Fernandes,Maria Pia Rigobello,Barbara Dani,Francesca Sorrentino,Francesco Tisato,Mikael Björnstedt,Alberto Bindoli,A. Sturaro,Rocco Rella,Cristina Marzano +10 more
TL;DR: Gold(I) compounds were found to induce antiproliferative effects towards several human cancer cells some of which endowed with cisplatin or multidrug resistance, and were able to activate caspase-3 and induce apoptosis observed as nucleosome formation and sub-G1 cell accumulation.
Journal ArticleDOI
A novel copper complex induces paraptosis in colon cancer cells via the activation of ER stress signalling.
Valentina Gandin,Maura Pellei,Francesco Tisato,Marina Porchia,Carlo Santini,Cristina Marzano +5 more
TL;DR: Light is shed on the signaling pathways involved in paraptosis thus offering a new tool to overcome apoptosis‐resistance in colon cancer cells, and providing a mechanistic characterization of CP‐induced cancer cell death.